Eosinophilic esophagitis: A review of the pediatric population and consideration of upcoming therapies

J Gastroenterol Hepatol. 2022 Mar;37(3):420-427. doi: 10.1111/jgh.15706. Epub 2021 Nov 6.

Abstract

Eosinophilic esophagitis (EoE) is a disease entity that has become increasingly recognized in the pediatric population over the last decade and was first recognized as early as 1990. EoE is a clinicopathologic diagnosis with signs and symptoms varying between age groups. The clinical presentation of EoE is variable ranging from milder nonspecific symptoms, such as abdominal pain, vomiting, and dyspepsia, to more severe presentations such as failure to thrive, dysphagia and even food impaction and is dependent on age of diagnosis 2. There is growing body of evidence with regards to the pathophysiology, diagnostic modalities, and treatment options for EoE in the past decade. In this review article, we aim to discuss the disease burden, pathophysiology, diagnostic strategies, and currently available treatment options for EoE based on existing literature.

Keywords: dysphagia; eosinophilic esophagitis (EoE); esophageal disorders; esophageal eosinophilia; esophageal food bolus impaction; esophagus; gastroenterology; pediatric dysphagia.

Publication types

  • Review

MeSH terms

  • Child
  • Eosinophilic Esophagitis* / diagnosis
  • Eosinophilic Esophagitis* / epidemiology
  • Eosinophilic Esophagitis* / physiopathology
  • Eosinophilic Esophagitis* / therapy
  • Humans